{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:54:10Z","timestamp":1788976450116,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009579","name":"Oxalosis and Hyperoxaluria Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009579","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["DK54468"],"award-info":[{"award-number":["DK54468"]}]},{"name":"Soci\u00e9t\u00e9 fran\u00e7aise de N\u00e9phrologie"},{"DOI":"10.13039\/100006280","name":"Urology Care Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006280","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.bbadis.2016.02.004","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T01:17:45Z","timestamp":1454807865000},"page":"1055-1062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay"],"prefix":"10.1016","volume":"1862","author":[{"given":"Sonia","family":"Fargue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross P.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gill","family":"Rumsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Danpure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2016.02.004_bb0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0014-5793(86)80563-4","article-title":"Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I","volume":"201","author":"Danpure","year":"1986","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0010","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/humu.21021","article-title":"Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene","volume":"30","author":"Williams","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2014070698","article-title":"Phenotype\u2013genotype correlations and estimated carrier frequencies of primary hyperoxaluria","author":"Hopp","year":"2015","journal-title":"JASN"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2014.12.029","article-title":"Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with primary hyperoxaluria type I: an overview","author":"Oppici","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/cs0380277","article-title":"The action of pyridoxine in primary hyperoxaluria","volume":"38","author":"Gibbs","year":"1970","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0030","first-page":"259","article-title":"Studies on some possible biochemical treatments of primary hyperoxaluria","volume":"48","author":"Watts","year":"1979","journal-title":"Q. J. Med."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0035","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00467-003-1234-x","article-title":"A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria","volume":"18","author":"Hoppe","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0040","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/ndt\/gfs078","article-title":"Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment","volume":"27","author":"Cochat","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0045","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/TP.0b013e31816de49e","article-title":"Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1","volume":"85","author":"Jiang","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000085408","article-title":"Feasibility of hepatocyte transplantation-based therapies for primary hyperoxalurias","volume":"25","author":"Guha","year":"2005","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0055","doi-asserted-by":"crossref","first-page":"G461","DOI":"10.1152\/ajpgi.00434.2010","article-title":"Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter","volume":"300","author":"Hatch","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0060","doi-asserted-by":"crossref","first-page":"14406","DOI":"10.1073\/pnas.1408401111","article-title":"Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1","volume":"111","author":"Miyata","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000085411","article-title":"Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria","volume":"25","author":"Monico","year":"2005","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0070","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1523-1755.2005.00267.x","article-title":"Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele","volume":"67","author":"Monico","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0075","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.06820613","article-title":"Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40years of practice","author":"Hoyer-Kuhn","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0080","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1523-1755.2004.00796.x","article-title":"Clinical implications of mutation analysis in primary hyperoxaluria type 1","volume":"66","author":"van Woerden","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0085","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1373\/clinchem.2006.084434","article-title":"Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1","volume":"53","author":"Williams","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0090","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.clinbiochem.2008.01.018","article-title":"Mutation-based diagnostic testing for primary hyperoxaluria type 1: survey of results","volume":"41","author":"Coulter-Mackie","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2014.222","article-title":"Outcome of primary hyperoxaluria type 1 correlates with AGXT mutation type: data from a large European study","author":"Mandrile","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0100","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1093\/ndt\/gfs320","article-title":"Primary hyperoxaluria type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort","volume":"27","author":"van der Hoeven","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0105","doi-asserted-by":"crossref","first-page":"8349","DOI":"10.1074\/jbc.M808965200","article-title":"Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine:glyoxylate aminotransferase and the F152I mutation","volume":"284","author":"Cellini","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0110","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.biochi.2010.08.005","article-title":"Human liver peroxisomal alanine:glyoxylate aminotransferase: different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant","volume":"92","author":"Cellini","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2013.04.010","article-title":"Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1","author":"Fargue","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0120","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1093\/hmg\/ddu329","article-title":"S81L and G170R mutations causing primary hyperoxaluria type I in homozygosis and heterozygosis: an example of positive interallelic complementation","volume":"23","author":"Montioli","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0125","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.bbapap.2010.12.005","article-title":"Human liver peroxisomal alanine:glyoxylate aminotransferase: characterization of the two allelic forms and their pathogenic variants","volume":"1814","author":"Cellini","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ymgme.2008.03.010","article-title":"Partial trypsin digestion as an indicator of mis-folding of mutant alanine:glyoxylate aminotransferase and chaperone effects of specific ligands. Study of a spectrum of missense mutants","volume":"94","author":"Coulter-Mackie","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10545-005-0243-2","article-title":"B6-responsive disorders: a model of vitamin dependency","volume":"29","author":"Clayton","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/BJ20051397","article-title":"Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells","volume":"394","author":"Behnam","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0145","article-title":"Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele","author":"Fargue","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/adt.2014.627","article-title":"Development of a phenotypic high-content assay to identify pharmacoperone drugs for the treatment of primary hyperoxaluria type 1 by high-throughput screening","volume":"13","author":"Madoux","year":"2015","journal-title":"Assay Drug Dev. Technol."},{"issue":"Pt 2","key":"10.1016\/j.bbadis.2016.02.004_bb0155","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/bj3520409","article-title":"The peroxisomal targeting sequence type 1 receptor, Pex5p, and the peroxisomal import efficiency of alanine:glyoxylate aminotransferase","volume":"352","author":"Knott","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0160","doi-asserted-by":"crossref","first-page":"36415","DOI":"10.1074\/jbc.M006693200","article-title":"Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations","volume":"275","author":"Lumb","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/bj20030371","article-title":"Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro","volume":"374","author":"Lumb","year":"2003","journal-title":"Biochem. J."},{"issue":"Pt 4","key":"10.1016\/j.bbadis.2016.02.004_bb0170","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/000456329703400411","article-title":"A semiautomated alanine:glyoxylate aminotransferase assay for the tissue diagnosis of primary hyperoxaluria type 1","volume":"34","author":"Rumsby","year":"1997","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0167-4781(00)00161-5","article-title":"Identification and expression of a cDNA for human glycolate oxidase","volume":"1493","author":"Williams","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0180","doi-asserted-by":"crossref","first-page":"C1359","DOI":"10.1152\/ajpcell.00238.2004","article-title":"Glycolate and glyoxylate metabolism in HepG2 cells","volume":"287","author":"Baker","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0185","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1073\/pnas.0908565107","article-title":"Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I","volume":"107","author":"Cellini","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0190","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pep.2004.11.004","article-title":"Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor","volume":"41","author":"Coulter-Mackie","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0195","first-page":"417","article-title":"Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation","volume":"53","author":"Danpure","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0300-9084(93)90091-6","article-title":"Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase","volume":"75","author":"Danpure","year":"1993","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0205","doi-asserted-by":"crossref","first-page":"20587","DOI":"10.1074\/jbc.274.29.20587","article-title":"Effect of N-terminal alpha-helix formation on the dimerization and intracellular targeting of alanine:glyoxylate aminotransferase","volume":"274","author":"Lumb","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0210","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1073\/pnas.1131968100","article-title":"Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase","volume":"100","author":"Santana","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0215","series-title":"Ph.D. thesis","article-title":"Human liver glycolate oxidase : gene identification and protein studies.","author":"Williams","year":"2003"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.toxlet.2007.06.010","article-title":"Calcium oxalate, and not other metabolites, is responsible for the renal toxicity of ethylene glycol","volume":"173","author":"Guo","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0225","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/ajkd.2001.26099","article-title":"Ethylene glycol-mediated tubular injury: identification of critical metabolites and injury pathways","volume":"38","author":"Poldelski","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093056","article-title":"C-phycocyanin confers protection against oxalate-mediated oxidative stress and mitochondrial dysfunctions in MDCK cells","volume":"9","author":"Farooq","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0235","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/bju.12642","article-title":"Oxalate at physiological urine concentrations induces oxidative injury in renal epithelial cells: effect of \u03b1-tocopherol and ascorbic acid","volume":"114","author":"Thamilselvan","year":"2014","journal-title":"BJU Int."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0240","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddv276","article-title":"Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I","author":"Oppici","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0245","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1083\/jcb.111.6.2341","article-title":"Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine\/glyoxylate aminotransferase in primary hyperoxaluria type 1","volume":"111","author":"Purdue","year":"1990","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0250","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/end.2013.0617","article-title":"Variability in kidney stone incidence between black and white South Africans: AGT Pro11Leu polymorphism is not a factor","volume":"28","author":"Theka","year":"2014","journal-title":"J. Endourol."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/BJ20070637","article-title":"Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications","volume":"408","author":"Cellini","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0260","doi-asserted-by":"crossref","first-page":"30493","DOI":"10.1074\/jbc.M803525200","article-title":"In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase","volume":"283","author":"Hopper","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0265","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.clinbiochem.2013.11.021","article-title":"The chaperone role of the pyridoxal 5\u2032-phosphate and its implications for rare diseases involving B6-dependent enzymes","volume":"47","author":"Cellini","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0270","article-title":"Measurement of plasma B(6) vitamer profiles in children with inborn errors of vitamin B(6) metabolism using an LC\u2013MS\/MS method","author":"Footitt","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0275","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1373\/clinchem.2005.051169","article-title":"Multianalyte quantification of vitamin B6 and B2 species in the nanomolar range in human plasma by liquid chromatography\u2013tandem mass spectrometry","volume":"51","author":"Midttun","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0280","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1373\/49.1.155","article-title":"Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study","volume":"49","author":"Bor","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0285","first-page":"256","article-title":"Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis","volume":"3","author":"Khan","year":"2014","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0290","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/j.1523-1755.2005.00576.x","article-title":"Oxalate is toxic to renal tubular cells only at supraphysiologic concentrations","volume":"68","author":"Schepers","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0295","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1021\/bi701710r","article-title":"Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design","volume":"47","author":"Murray","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0300","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.biochi.2012.02.003","article-title":"High resolution crystal structure of rat long chain hydroxy acid oxidase in complex with the inhibitor 4-carboxy-5-[(4-chlorophenyl)sulfanyl]-1, 2, 3-thiadiazole. implications for inhibitor specificity and drug design","volume":"94","author":"Chen","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbadis.2015.12.001","article-title":"Metabolism of 13C5-hydroxyproline in mouse models of primary hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase","volume":"1862","author":"Li","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2016.02.004_bb0310","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1534\/genetics.112.143750","article-title":"Rapid profiling of disease alleles using a tunable reporter of protein misfolding","volume":"192","author":"Pittman","year":"2012","journal-title":"Genetics"},{"key":"10.1016\/j.bbadis.2016.02.004_bb0315","doi-asserted-by":"crossref","first-page":"18249","DOI":"10.1073\/pnas.0607218103","article-title":"Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer","volume":"103","author":"Salido","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916300308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916300308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T17:28:53Z","timestamp":1537032533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443916300308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0925443916300308"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.02.004","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}